This Communique covers matters considered at the 21st meeting of the Gene Technology Ethics and Community Consultative Committee (25 February 2025).
Commercial supply of multivalent cat vaccines containing a genetically modified component for the prevention of feline leukemia virus infection
Trial of genetically modified vaccines against Ross River virus infection in horses
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2024-25.
This issue focuses on 50 years since The Asilomar Conference.
GTECCC’s story-telling case studies for communicating on gene technology.
Our committees provide advice to the Gene Technology Regulator and the Gene Technology Ministers’ Meeting.
Clinical trial of genetically modified adenovirus for treatment of locally advanced rectal cancer
Clinical trial of a genetically modified adenovirus for treatment of bladder cancer